Netarsudil: all 32 studies that test it

Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.

• Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma PatientsRecruitingNCT07847073Phase 4
• Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular HypertensionRecruitingNCT07588152Phase 4
• 24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension PatientsRecruitingNCT07325240Phase 4
• Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal DetachmentRecruitingNCT06033703Phase 1/2
• Rocklatan® EvaluationCompletedNCT05283395Phase 4Results posted
• Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT04620135Phase 3Results posted
• A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal DystrophyCompletedNCT04498169Phase 2Results posted
• Rhopressa for Corneal Edema Associated With Fuchs DystrophyCompletedNCT04051463Phase 2/3Results posted
• Trial of Netarsudil for Acceleration of Corneal Endothelial RestorationTerminatedNCT03971357Phase 2/3Results posted
• Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in JapanCompletedNCT03844945Phase 2Results posted
• Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world SettingCompletedNCT03808688Phase 4Results posted
• Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular HypertensionCompletedNCT03310580Phase 2Results posted
• Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure ElevationCompletedNCT03248037Phase 3Results posted
• Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT03233308Phase 2Results posted
• Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic SolutionCompletedNCT02874846Phase 2Results posted
• Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular HypertensionCompletedNCT02558374Phase 3Results posted
• Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT02246764Phase 3Results posted
• Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular HypertensionCompletedNCT02207621Phase 3Results posted
• Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT02207491Phase 3Results posted
• Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular PressureCompletedNCT01731002Phase 2Results posted
• Study of AR-13324 in Patients With Elevated Intraocular PressureCompletedNCT01528787Phase 2Results posted
• Reformulated PG324 Ophthalmic Solution for Intraocular Pressure ReductionCompletedNCT07082816Phase 3
• The Effect of ROCK Inhibitors on Corneas of Patients With Glaucoma and Pseudophakic Bullous Keratopathy (PBK)CompletedNCT06960629Phase 2/3
• Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLTActive, not recruitingNCT06865144Phase 4
• Effect of Netarsudil vs Brimonidine in NTG Patients on LatanoprostCompletedNCT06449352Phase 4
• A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVRStatus unknownNCT05660447Phase 2/3
• Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension GlaucomaStatus unknownNCT04981886Phase 4
• Netarsudil Use After Descemtorhexis Without Endothelial KeratoplastyCompletedNCT04752020Early Phase 1
• Short-term Effect of Rho-kinase Inhibitor on Retinal CirculationStatus unknownNCT04234932Early Phase 1
• Netarsudil Use After Descemetorhexis Without Endothelial KeratoplastyCompletedNCT04057053Early Phase 1
• A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult VolunteersCompletedNCT02406287Phase 1
• Study Assessing Ocular and Systemic Safety of AR-13324 in Healthy VolunteersCompletedNCT01997879Phase 1

← Netarsudil overview